Sources | Names Used |
---|---|
CTRPv2 | alisertib:navitoclax (2:1 mol/mol) |
PharmacoGx | alisertib:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PPP1R13B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF714 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CCSAP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | KDF1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | STMN4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | WEE2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | ZNF596 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | AP3M2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | KIAA1549L | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | CLEC11A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |